PDLIEUR Institutional Ownership & Shareholders
PDL BIOPHARMA INC (PDLIEUR) is currently held by 2 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $29,240 based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.
Diversified Trust Co is currently the largest disclosed institutional shareholder of PDLIEUR tracked by InsiderSet, reporting ownership valued at approximately $27,729 in its June 30, 2026 SEC Form 13F filing.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed PDLIEUR value among the investors covered in this analysis. Major shareholders include Diversified Trust Co, Rhumbline Advisers, and several other long-term asset managers with concentrated positions in PDL BIOPHARMA INC (PDLIEUR).
This page ranks the largest institutional PDLIEUR shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
2
Total Reported Value
$29,240
Largest Holder
Diversified Trust Co
Largest Position
$27,729
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
10
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Diversified Trust Co | 0.00% | 11,554 | $27,729 | — | — | — | |
| Rhumbline Advisers | 0.00% | 612 | $1,511 | — | — | — |
Frequently asked questions about PDLIEUR
Who are the largest institutional holders of PDLIEUR?
The largest institutional holders of PDLIEUR reported in the latest SEC Form 13F filings include Diversified Trust Co and Rhumbline Advisers. InsiderSet ranks institutional holders by their latest reported PDLIEUR position.
What is PDLIEUR institutional ownership?
This page tracks PDLIEUR positions reported by institutional investment managers through SEC Form 13F. PDL BIOPHARMA INC (PDLIEUR) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.
How many institutions own PDLIEUR?
InsiderSet currently tracks 2 institutional managers reporting PDLIEUR holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of PDLIEUR shareholders.
How much PDLIEUR stock do institutions own?
Institutional investment managers disclosed approximately $29,240 in PDLIEUR holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.
When was PDLIEUR institutional ownership last updated?
The latest PDLIEUR institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.
Are institutional PDLIEUR holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its PDLIEUR position after the reporting date.
Are institutions buying or selling PDLIEUR?
Institutional buying and selling can be analyzed by comparing PDLIEUR positions across consecutive 13F reporting periods. InsiderSet's PDLIEUR Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View PDLIEUR ownership changes.
How has PDLIEUR institutional ownership changed over time?
InsiderSet tracks PDLIEUR institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.